Date Initiated by Firm | December 16, 2009 |
Date Posted | September 08, 2010 |
Recall Status1 |
Terminated 3 on October 25, 2010 |
Recall Number | Z-2385-2010 |
Recall Event ID |
54460 |
510(K)Number | K994115 |
Product Classification |
Ferrozine (colorimetric) iron binding capacity - Product Code JMO
|
Product | Dimension IBCT Flex Reagent Cartridge. The total (IBCT) method used on the Dimension system is an in vitro diagnostic test intended to quantitatively measure Total Iron Binding capacity in human serum and plasma. |
Code Information |
Catalog number df84 |
Recalling Firm/ Manufacturer |
Siemens Healthcare Diagnostics, Inc. 500 GBC Drive, Mailstop 514 PO BOX 6101 Newark DE 19714-6101
|
For Additional Information Contact | Anne Lara 302-631-6311 |
Manufacturer Reason for Recall | Test produces falsely elevated IBCT results and Abnormal Reaction test report messages on heparinized plasma samples. |
FDA Determined Cause 2 | Nonconforming Material/Component |
Action | Siemens issued an "Urgent Field Safety Notice" letter dated December 2009 to users identifying the issue and affected product. Customers were instructed not to use heparinized plasma samples for IBCT testing. IBCT Instructions for Use (IFU) has been updated to reflect that heparinized plasma is no longer an acceptable sample type. Beginning with lot ED0341, the new IFU will be packaged in the carton with the IBCT Flex reagent cartridges. Consignees were requested to forward the notification letter to anyone to whom the product was distributed. The Siemens Technical Solutions Center can be contacted at 800-441-9250. |
Quantity in Commerce | unknown - all lots involved |
Distribution | Worldwide Distribution: USA (all states) and the countries of Canada, Switzerland, New Zealand, Australia, Japan, and South Korea. |
Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
510(K) Database | 510(K)s with Product Code = JMO
|